Macromolecular prodrugs of ribavirin combat side effects and toxicity with no loss of activity of the drug

Mille B. L. Kryger, Benjamin M. Wohl, Anton A. A. Smith, Alexander N. Zelikin
  • Chemical Communications, January 2013, Royal Society of Chemistry
  • DOI: 10.1039/c3cc00315a